Effects of the naturally occurring arginine analogues indospicine and canavanine on nitric oxide mediated functions in aortic endothelium and peritoneal macrophages.
The ability of the naturally occurring non-protein toxic amino acids indospicine and canavanine to inhibit nitric oxide synthesis was tested in isolated rat aorta and cultured rat peritoneal macrophages. Both compounds inhibited acetylcholine induced relaxation of rat aorta contracted with noradrenaline, a process mediated by nitric oxide generated in vascular endothelium. Nitric oxide is generated in vascular endothelium from arginine by a constitutive nitric oxide synthase. Indospicine and canavanine also increased superoxide mediated reduction of cytochrome c by phorbol myristate acetate stimulated rat peritoneal macrophages. The increase in superoxide under these conditions was due to decreased nitric oxide synthesis. Macrophage synthesis of nitric oxide is mediated by an inducible form of nitric oxide synthase. It is concluded that indospicine and canavanine are inhibitors of constitutive and inducible nitric oxide synthases and it is suggested that the toxicity associated with these compounds could be related to this activity.
Pass
M A
MA
Department of Physiology and Pharmacology, University of Queensland, Australia.
Arab
H
H
Pollitt
S
S
Hegarty
M P
MP
D000818:Animals; D001011:Aorta; D001120:Arginine / Q000031:analogs & derivatives / Q000633:toxicity; D001500:BCG Vaccine / Q000008:administration & dosage; D002172:Canavanine / Q000633:toxicity*; D002478:Cells, Cultured; D003574:Cytochrome c Group / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects*; D004790:Enzyme Induction / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000633:toxicity; D017737:Macrophages, Peritoneal / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000633:toxicity; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009646:Norleucine / Q000031:analogs & derivatives* / Q000633:toxicity; D010084:Oxidation-Reduction; D051381:Rats; D017208:Rats, Wistar; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D019323:omega-N-Methylarginine / Q000633:toxicity
D001500:BCG Vaccine; D003574:Cytochrome c Group; D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D002172:Canavanine; D009646:Norleucine; D001120:Arginine; D019001:Nitric Oxide Synthase; D013755:Tetradecanoylphorbol Acetate; D019331:NG-Nitroarginine Methyl Ester; C058318:indospicine